Subscribe To
THKKF / Think Research on a mission to become an essential data service for clinicians everywhere
THKKF News
By Proactive Investors
November 28, 2022
Think Research posts 82% jump in 3Q revenue on optimized operations and streamlined costs
Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) has posted its financial results for the three months and nine months ended September 30, showing more_horizontal
By Proactive Investors
November 22, 2022
Think Research says Beedie Investments approves second advance from current credit agreement; gives positive outlook
Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) says Beedie Investments Ltd has continued to show its support of the company with a second advanc more_horizontal
By Proactive Investors
August 29, 2022
Think Research reports 80% year-over-year surge in 2Q revenue
Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) has reported second-quarter results, posting a significant year-over-year revenue bump and issuin more_horizontal
By Proactive Investors
July 6, 2022
Think Research signs contract to provide Care Pathways nursing content to St. George's University Hospitals
Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) said it has signed a contract to provide Care Pathways nursing content to St. George's University more_horizontal
By Proactive Investors
June 28, 2022
Think Research Corporation wins contract from major US pharmacy to deliver business intelligence and support solutions
Think Research Corporation (TSX-V:THNK, OTCQB:THKKF) said it has been contracted by a major US-based pharmacy to deliver business intelligence and sup more_horizontal
By Proactive Investors
June 1, 2022
Canaccord Genuity repeats 'Speculative Buy' rating and $2.00 price target on Think Research after its Q1 results beat expectations
Canaccord Genuity (TSX:CF, LSE:CF) analysts have repeated a 'Speculative Buy' rating and $2.00 price target on Think Research Corporation (TSX-V:THNK) more_horizontal
By Proactive Investors
May 30, 2022
Think Research reports record first-quarter revenue as software and data solutions business continues to grow
Think Research Corporation (TSX-V:THNK) has reported record sales for the first quarter to March 31, 2022, driven by continued growth in the company's more_horizontal
By Proactive Investors
May 19, 2022
Think Research enters $4.1M content and learning management agreement with global pharmaceutical company
Think Research Corporation (TSX-V:THNK) has announced that its MDBriefcase Group Inc subsidiary has been chosen by a global pharmaceutical company to more_horizontal